Skip to main content
  1. Right Decisions
  2. Back
  3. Vascular surgery pathways
  4. Abdominal aortic aneurysm national pathway
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Abdominal aortic aneurysm national pathway

Warning

Background

An Abdominal Aortic Aneurysm (AAA) is a dilatation of the main artery in the abdomen which, once it reaches a certain size, may rupture and, without emergency treatment, this is likely to prove fatal. Ideally, AAAs should be detected prior to rupture so that they can be repaired surgically in a planned, elective manner.

Abdominal Aortic Aneurysms (AAA) are currently identified by two different paths. The majority are found incidentally as a consequence of a scan for some other reason, the remainder by the National AAA Screening Programme, where men aged 65 are invited to participate in AAA abdominal ultrasound screening. Those found to have a large AAA (equal to or greater than 5.5cm in AP diameter) are referred urgently to Vascular Services. The AAA Screening Programme, via the Key performance Indicators, dictates that men who are found to have a large AAA are seen and treated within 8 weeks.

The Provision of Vascular Services 2021 document from the Vascular Society of Great Britain and Ireland states that all AAA above threshold, irrespective of how they were detected, should be treated in a similar manner with patients being seen within 2 weeks of diagnosis and being treated within 8 weeks. Previously, due to limited resources for assessment and intervention on AAA, screen-detected aneurysms may have been prioritised over those found incidentally. Currently those patients with an AAA discovered incidentally tend to wait longer for assessment and treatment compared to those with a screen-detected AAA leading to unacceptable inequality.

A single pathway should be established for all patients with aneurysms in Scotland, supported by a dedicated local co-ordinator, an efficient ‘one stop’ pre-operative assessment service, with ‘lifestyle’ advice given at the time of diagnosis, as well as adequate resource for timely operative intervention. For most patients it should be possible to complete this within 8 weeks of diagnosis.

 

Pathway overview

Click on the image to view a larger version

Triage and review

All patients with an AAA of 5.5cm or above should be actively triaged and seen by a Vascular Specialist within 2 weeks of their diagnostic imaging. At this review, patients can be assessed for their suitability for intervention, informed about the implications of having an AAA and the options for treatment, and be given appropriate lifestyle advice. Cardiovascular risk factors should be addressed, including smoking cessation.

 

One-stop assessment clinic

Repair of an AAA is a significant intervention and patients require further investigation prior to a decision on treatment being made. As intervention for AAA is time-critical, this assessment process is best delivered in a one stop clinic where patients can undergo CT scanning and appropriate cardiorespiratory assessment, such as cardiopulmonary exercise testing, on the same day. This is time efficient and also more convenient for patients, avoiding repeated out-patient appointments.

There is no gold standard for cardiorespiratory assessment and so locally agreed protocols for investigation should be followed.

 

Anaesthetic review

Patients undergoing AAA repair should be reviewed by an anaesthetist with an interest in vascular patients. It may be possible to combine this with the one-stop assessment clinic or else this may take place separately.

Some patients will require further investigation following anaesthetic review and local pathways for this should be in place.

 

Multi-disciplinary team meeting

All patients with an AAA should be discussed at a weekly MDT meeting which should include at least 2 vascular surgeons, 2 interventional radiologists or those with appropriate endovascular experience, and a vascular anaesthetist.

Core members should have attendance recognised in their job plans and there should be equal access for clinicians working at the arterial centre and those working in spoke sites.

Decisions should be documented in the patient’s notes. Some patients will be found to have a complex abdominal or thoraco-abdominal aortic aneurysm and would not be suitable for conventional infrarenal open or endovascular repair. Such patients should be discussed at the Scottish TAA and Complex Aortic Surgery MDT.

Following a decision at the MDT, patients should be reviewed in a timely fashion and treatment options can be discussed and a treatment plan, with a fully informed patient, made.

 

Intervention

Treatment of an AAA can involve open repair or endovascular repair and is time-critical once it has reached threshold. Repair should be performed in a centre performing sufficient numbers of cases as stated in the Provision of Services for People with Vascular Diseases 2021 document.

Adequate theatre resource, including staff, must be available to treat patients within an acceptable time and, for endovascular aneurysm repair, this should be performed in a hybrid operating theatre. Open surgery to repair an AAA is a significant operation and is associated with recognised morbidity and mortality. Centres performing this should have access to appropriate critical care and renal support services. For endovascular repair, there must be sufficient provision of interventional radiology services with availability of appropriately trained personnel.

 

Monitoring and clinical governance

To support implementation and ongoing clinical governance units will submit all AAA cases that undergo intervention to the National Vascular Registry. Units should regularly review their outcomes compared to those for the rest of the country.

 

References and further resources

  1. Scottish AAA screening programme statistics – year ending March 2021
    https://www.publichealthscotland.scot/media/11937/2022-03-01-aaa-publication-report.pdf
  2. Provision of Services for People with Vascular Diseases 2021. Vascular Society of Great Britain and Ireland https://vascularsociety.org.uk/_userfiles/pages/files/povs/povs-2021.pdf
  3. NICE 2020. NICE guideline [NG156]: Abdominal aortic aneurysm: diagnosis and management. https://www.nice.org.uk/guidance/ng156

 

   gjnh.cfsdpmo@gjnh.scot.nhs.uk

  www.nhscfsd.co.uk

@NHSScotCfSD

Centre for Sustainable Delivery

  Scan the code to visit our website

Editorial Information

Last reviewed: 31/05/2023

Next review date: 31/05/2026

Author(s): Centre for Sustainable Delivery.